Q3. During the lectures of Part-14, you learned that anti-CD20 antibodies coupled with a potent-toxin may...

60.1K

Verified Solution

Question

Medical Sciences

Q3. During the lectures of Part-14, you learned thatanti-CD20 antibodies coupled with a potent-toxin may be used tokill tumor B cells.
Suppose that CD20 is expressed on by hematopoietic stemcells and all the developmental stages of B cells.
Do you think that in this case, anti-CD20 antibodiescoupled with a potent-toxin can still be used to kill B cell tumorcells?
Yes, Noâ€¦.please explain why.

Answer & Explanation Solved by verified expert

4.0 Ratings (577 Votes)

CD20 is surface Bcell marker CD20 is a general B cell marker that is expressed during B cell differentiation from the proB cell phase until the plasma cell stadium Yes antiCD20antibodies coupled with a potenttoxin can still be used to kill B cell tumor cells because Therapeutic monoclonal antibodies mAbs that target the CD20 antigen on B cells are successfully used in the clinic for the depletion of B cells to treat various forms of cancer and autoimmune diseasesCD20 mAbs can induce tumor killing via various mechanisms such as direct induction of apoptosis See Answer

Get Answers to Unlimited Questions

Join us to gain access to millions of questions and expert answers. Enjoy exclusive benefits tailored just for you!

Membership Benefits:

Unlimited Question Access with detailed Answers
Zin AI - 3 Million Words
10 Dall-E 3 Images
20 Plot Generations
Conversation with Dialogue Memory
No Ads, Ever!
Access to Our Best AI Platform: Flex AI - Your personal assistant for all your inquiries!

Become a Member